16.7
Botulism is a severe neuroparalytic illness caused by the botulinum toxin, which is produced by Clostridium botulinum.
In adults, it occurs either after consuming food contaminated with preformed toxin or when the bacterium infects a wound and produces the toxin locally.
In localized infection, the bacterium synthesizes an inactive form of the botulinum toxin, composed of a heavy and a light chain linked by a disulfide bond.
When the toxin is ingested, it crosses intestinal epithelial cells through transcytosis and enters the bloodstream.
From there, it spreads into neuromuscular junctions and targets nerve endings that release acetylcholine.
The toxin enters the nerve cell through endocytosis.
Endosome acidification triggers cleavage of the disulfide bond, releasing the catalytically active light chain into the cytosol.
The light chain acts as a protease that cuts SNARE proteins needed for synaptic vesicle fusion and acetylcholine release.
Blocking acetylcholine release prevents muscle contraction, leading to weakness and flaccid paralysis.
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.
In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly occurs after ingestion of spores, such as those from honey, which germinate in the intestine. These spores colonize the immature gut, where limited microbiota and reduced colonization resistance allow bacterial growth and continuous toxin production in situ. This contrasts with adult botulism, where the disease is typically caused by exposure to preformed toxin or localized toxin release from a wound. As a result, infant botulism involves sustained toxin exposure driven by microbial proliferation, rather than acute systemic exposure following ingestion.
Clostridial Species and Toxin Types
Clostridium botulinum, along with several related clostridial species, is associated with seven distinct botulinum neurotoxins (BoNTs) classified as serotypes A through G. These species include C. sporogenes, C. novyi sensu lato, C. baratii, C. butyricum, and C. argentinense. Among them, all strains of C. botulinum collectively produce all seven serotypes, each showing different patterns of occurrence. Of these, serotypes A, B, E, and F are responsible for most foodborne botulism cases worldwide.
Structure and Activation of Botulinum Toxin
BoNT is a 150 kDa zinc-dependent metalloprotease composed of a heavy chain (~100 kDa) and a light chain (~50 kDa) connected by a disulfide bond. It is synthesized as an inactive polypeptide. Activation requires proteolytic cleavage and reduction of the disulfide bond. The heavy chain enables binding and internalization at cholinergic motor nerve terminals through receptor-mediated endocytosis.
Mechanism of Neurotransmission Blockade
Once inside the neuron, endosomal acidification induces a conformational change in the heavy chain, allowing the light chain to translocate into the cytosol. The light chain, a zinc-dependent endopeptidase, cleaves SNARE (Soluble NSF Attachment Protein Receptor) proteins—such as synaptobrevin, SNAP-25, or syntaxin—depending on the toxin serotype (A–G). These proteins are essential for synaptic vesicle fusion and acetylcholine release. Their cleavage blocks neurotransmission at the neuromuscular junction.
Clinical Effects and Recovery
The resulting inhibition of acetylcholine release causes flaccid paralysis. Early symptoms often include diplopia, ptosis, and dysphagia. Without timely intervention, respiratory failure may develop. Recovery depends on the regeneration of motor nerve terminals, a process that can take weeks to months. Supportive care and prompt administration of antitoxin are critical to improving outcomes.
Botulism is a severe neuroparalytic illness caused by the botulinum toxin, which is produced by Clostridium botulinum.
In adults, it occurs either after consuming food contaminated with preformed toxin or when the bacterium infects a wound and produces the toxin locally.
In localized infection, the bacterium synthesizes an inactive form of the botulinum toxin, composed of a heavy and a light chain linked by a disulfide bond.
When the toxin is ingested, it crosses intestinal epithelial cells through transcytosis and enters the bloodstream.
From there, it spreads into neuromuscular junctions and targets nerve endings that release acetylcholine.
The toxin enters the nerve cell through endocytosis.
Endosome acidification triggers cleavage of the disulfide bond, releasing the catalytically active light chain into the cytosol.
The light chain acts as a protease that cuts SNARE proteins needed for synaptic vesicle fusion and acetylcholine release.
Blocking acetylcholine release prevents muscle contraction, leading to weakness and flaccid paralysis.
From Chapter 16:
Now Playing
Bacterial Diseases
59 Views
Bacterial Diseases
386 Views
Bacterial Diseases
175 Views
Bacterial Diseases
53 Views
Bacterial Diseases
41 Views
Bacterial Diseases
47 Views
Bacterial Diseases
48 Views
Bacterial Diseases
26 Views
Bacterial Diseases
124 Views
Bacterial Diseases
303 Views
Bacterial Diseases
158 Views
Bacterial Diseases
45 Views
Bacterial Diseases
107 Views
Bacterial Diseases
184 Views
Bacterial Diseases
262 Views